Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

The neuroprotective effects of caffeine in neurodegenerative diseases
Mahshad Kolahdouzan, Mazen J. Hamadeh
CNS Neuroscience & Therapeutics (2017) Vol. 23, Iss. 4, pp. 272-290
Open Access | Times Cited: 248

Showing 1-25 of 248 citing articles:

From purines to purinergic signalling: molecular functions and human diseases
Zhao Huang, Na Xie, Péter Illés, et al.
Signal Transduction and Targeted Therapy (2021) Vol. 6, Iss. 1
Open Access | Times Cited: 303
Health Benefits and Chemical Composition of Matcha Green Tea: A Review
Joanna Kochman, Karolina Jakubczyk, Justyna Antoniewicz, et al.
Molecules (2020) Vol. 26, Iss. 1, pp. 85-85
Open Access | Times Cited: 214
Neuroprotective Effects of Coffee Bioactive Compounds: A Review
Katarzyna Socała, Aleksandra Szopa, Anna Serefko, et al.
International Journal of Molecular Sciences (2020) Vol. 22, Iss. 1, pp. 107-107
Open Access | Times Cited: 182
Role of natural products for the treatment of Alzheimer's disease
Tayebeh Noori, Ahmad Reza Dehpour, Antoni Sureda, et al.
European Journal of Pharmacology (2021) Vol. 898, pp. 173974-173974
Closed Access | Times Cited: 118
Caffeine as a Factor Influencing the Functioning of the Human Body—Friend or Foe?
Kamil Rodak, Izabela Kokot, Ewa Maria Kratz
Nutrients (2021) Vol. 13, Iss. 9, pp. 3088-3088
Open Access | Times Cited: 109
Parkinson's Disease: A Multisystem Disorder
Helena Nunes Costa, A. Raquel Esteves, Nuno Empadinhas, et al.
Neuroscience Bulletin (2022) Vol. 39, Iss. 1, pp. 113-124
Closed Access | Times Cited: 82
Polyphenols, Alkaloids, and Terpenoids Against Neurodegeneration: Evaluating the Neuroprotective Effects of Phytocompounds Through a Comprehensive Review of the Current Evidence
Enzo Pereira de Lima, Lucas Fornari Laurindo, Vitor Cavallari Strozze Catharin, et al.
Metabolites (2025) Vol. 15, Iss. 2, pp. 124-124
Open Access | Times Cited: 5
Caffeine Modulates Cadmium-Induced Oxidative Stress, Neuroinflammation, and Cognitive Impairments by Regulating Nrf-2/HO-1 In Vivo and In Vitro
Amjad Khan, Muhammad Ikram, Tahir Muhammad, et al.
Journal of Clinical Medicine (2019) Vol. 8, Iss. 5, pp. 680-680
Open Access | Times Cited: 119
Neuroprotective Effects and Mechanisms of Tea Bioactive Components in Neurodegenerative Diseases
Shuqing Chen, Wang Ze-shi, Yixiao Ma, et al.
Molecules (2018) Vol. 23, Iss. 3, pp. 512-512
Open Access | Times Cited: 110
Alzheimer’s Disease, Inflammation, and the Role of Antioxidants
Benjamin Sinyor, Jocelyn Mineo, Christopher N. Ochner
Journal of Alzheimer s Disease Reports (2020) Vol. 4, Iss. 1, pp. 175-183
Open Access | Times Cited: 96
The Effect of Caffeine on the Risk and Progression of Parkinson’s Disease: A Meta-Analysis
Chien‐Tai Hong, Lung Chan, Chyi‐Huey Bai
Nutrients (2020) Vol. 12, Iss. 6, pp. 1860-1860
Open Access | Times Cited: 90
Implications of DNA Methylation in Parkinson’s Disease
Ernesto G. Miranda-Morales, Karin Meier, Ada Agustina Sandoval-Carrillo, et al.
Frontiers in Molecular Neuroscience (2017) Vol. 10
Open Access | Times Cited: 88
Nutritional Risk Factors, Microbiota and Parkinson’s Disease: What Is the Current Evidence?
Christa Boulos, Nathalie Yaghi, Rita El Hayeck, et al.
Nutrients (2019) Vol. 11, Iss. 8, pp. 1896-1896
Open Access | Times Cited: 86
Caffeine May Abrogate LPS-Induced Oxidative Stress and Neuroinflammation by Regulating Nrf2/TLR4 in Adult Mouse Brains
Haroon Badshah, Muhammad Ikram, Waqar Ali, et al.
Biomolecules (2019) Vol. 9, Iss. 11, pp. 719-719
Open Access | Times Cited: 84
Whole-blood metabolomics of dementia patients reveal classes of disease-linked metabolites
Takayuki Teruya, Yung-Ju Chen, Yasuhide Fukuji, et al.
Proceedings of the National Academy of Sciences (2021) Vol. 118, Iss. 37
Open Access | Times Cited: 81
Potential of Caffeine in Alzheimer’s Disease—A Review of Experimental Studies
Piotr Londzin, Milena Zamora, Beata Kąkol, et al.
Nutrients (2021) Vol. 13, Iss. 2, pp. 537-537
Open Access | Times Cited: 60
Targeting whole body metabolism and mitochondrial bioenergetics in the drug development for Alzheimer's disease
Steven N. Austad, Scott W. Ballinger, Thomas W. Buford, et al.
Acta Pharmaceutica Sinica B (2021) Vol. 12, Iss. 2, pp. 511-531
Open Access | Times Cited: 56
Bioactive Compounds and Antioxidant Activity from Spent Coffee Grounds as a Powerful Approach for Its Valorization
Carolina Andrade, Rosa Perestrelo, José S. Câmara
Molecules (2022) Vol. 27, Iss. 21, pp. 7504-7504
Open Access | Times Cited: 52
The role of dietary antioxidants in type 2 diabetes and neurodegenerative disorders: An assessment of the benefit profile
Munazza Fatima, Ajaz A. Bhat, Sabah Nisar, et al.
Heliyon (2022) Vol. 9, Iss. 1, pp. e12698-e12698
Open Access | Times Cited: 43
Special tea products featuring functional components: Health benefits and processing strategies
Gaozhong Yang, Qing Meng, Jiang Shi, et al.
Comprehensive Reviews in Food Science and Food Safety (2023) Vol. 22, Iss. 3, pp. 1686-1721
Closed Access | Times Cited: 30
Overview of Caffeine Effects on Human Health and Emerging Delivery Strategies
Sofia M. Saraiva, Telma A. Jacinto, Ana C. Gonçalves, et al.
Pharmaceuticals (2023) Vol. 16, Iss. 8, pp. 1067-1067
Open Access | Times Cited: 25
A longitudinal cohort study demonstrating the beneficial effect of moderate consumption of green tea and coffee on the prevention of dementia: The JPHC Saku Mental Health Study
Akihiro Koreki, Shoko Nozaki, Ryo Shikimoto, et al.
Journal of Alzheimer s Disease (2025)
Closed Access | Times Cited: 1
Neuroprotective and Neuro-restorative Effects of Minocycline and Rasagiline in a Zebrafish 6-Hydroxydopamine Model of Parkinson’s Disease
Aileen Cronin, Maura Grealy
Neuroscience (2017) Vol. 367, pp. 34-46
Closed Access | Times Cited: 63
Adenosine A2A receptor as potential therapeutic target in neuropsychiatric disorders
Maria Rosaria Domenici, Antonella Ferrante, Alberto Martire, et al.
Pharmacological Research (2019) Vol. 147, pp. 104338-104338
Closed Access | Times Cited: 61
Page 1 - Next Page

Scroll to top